AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
1 tracks • 0 plays • 0 favorites
AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
Simolabhaj
0:001:35
Entrepreneurship Strategy
Episodes
1
AstraZeneca: COVID vaccine 79% effective in U.S. trial - Morning Briefing - Marketplace Minute - March 22, 2021
Simolabhaj